GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FluoGuide AS (OSTO:FLUO) » Definitions » ROE % Adjusted to Book Value

FluoGuide AS (OSTO:FLUO) ROE % Adjusted to Book Value : -8.60% (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is FluoGuide AS ROE % Adjusted to Book Value?

FluoGuide AS's ROE % for the quarter that ended in Dec. 2024 was -128.94%. FluoGuide AS's PB Ratio for the quarter that ended in Dec. 2024 was 14.99. FluoGuide AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -8.60%.


FluoGuide AS ROE % Adjusted to Book Value Historical Data

The historical data trend for FluoGuide AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FluoGuide AS ROE % Adjusted to Book Value Chart

FluoGuide AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -2.51 -6.07 -8.56 -4.44 -10.90

FluoGuide AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.43 -5.00 -14.51 -5.57 -8.60

Competitive Comparison of FluoGuide AS's ROE % Adjusted to Book Value

For the Biotechnology subindustry, FluoGuide AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FluoGuide AS's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FluoGuide AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where FluoGuide AS's ROE % Adjusted to Book Value falls into.


;
;

FluoGuide AS ROE % Adjusted to Book Value Calculation

FluoGuide AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-163.41% / 14.99
=-10.90%

FluoGuide AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-128.94% / 14.99
=-8.60%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FluoGuide AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of FluoGuide AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


FluoGuide AS Business Description

Industry
Traded in Other Exchanges
Address
Titanhus, Titangade 9-13, Copenhagen, DNK, DK-2200
FluoGuide AS is a clinical-stage biotechnology company focused on developing drugs that maximize surgical outcomes by making cancer fluorescent. Its technology includes uPAR, which is part of a proteolytic system, and FG001, a product injected into the patient's vein prior to surgery.

FluoGuide AS Headlines

No Headlines